Hubei Biocause Pharmaceutical Co., Ltd.
Hubei Biocause Pharmaceutical Co., Ltd., commonly referred to as Biocause, is a prominent player in the pharmaceutical industry, headquartered in Hubei, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of antibiotics and anti-infectives. With a strong operational presence across various regions in China and beyond, Biocause is dedicated to innovation and excellence. The company’s core offerings include a diverse range of active pharmaceutical ingredients (APIs) and finished dosage forms, distinguished by their adherence to stringent quality standards and regulatory compliance. Recognised for its commitment to research and development, Hubei Biocause has achieved notable milestones, positioning itself as a trusted partner in the global pharmaceutical market.
DitchCarbon Score
How does Hubei Biocause Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hubei Biocause Pharmaceutical Co., Ltd.'s score of 12 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hubei Biocause Pharmaceutical Co., Ltd.'s reported carbon emissions
Hubei Biocause Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there is no available emissions data or climate pledges, Hubei Biocause Pharmaceutical Co., Ltd. appears to be in the early stages of addressing its carbon footprint and climate impact. The pharmaceutical industry is increasingly focusing on sustainability and emissions reduction, and it is essential for companies like Hubei Biocause to develop and implement strategies to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hubei Biocause Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
